Skip to content

Ane Suositus Malignin Hypertermian Riski

by Oy Apotti Ab EUDAMED

Active European Union

Ref OLL0001107 ANE SUOSITUS MALIGNIN HYPERTERMIAN RISKI

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-OLL0001107N6 Basic UDI-DIDate21 Feb 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
Ane Suositus Malignin Hypertermian Riski
Model / Reference
OLL0001107 ANE SUOSITUS MALIGNIN HYPERTERMIAN RISKI
Primary DI / UDI-DI
D-OLL0001107N6
Basic UDI-DI
B-OLL0001107N6
EMDN Code
V92 Medical device software - not included in other classes
Device Class
Class I
Special Device Type
-1192
Market of Registration
Finland

Manufacturer details

EUDAMED SRN
FI-MF-000007544

Other devices from Oy Apotti Ab

See all devices from Oy Apotti Ab →

Properties

Other properties (11)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No